Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

PubWeight™: 2.63‹?› | Rank: Top 1%

🔗 View Article (PMID 9820866)

Published in Pathol Res Pract on January 01, 1998

Authors

T Brabletz1, A Jung, K Hermann, K Günther, W Hohenberger, T Kirchner

Author Affiliations

1: Department of Pathology, University of Erlangen-Nürnberg, Germany. Thomas.Brabletz@Patho.Med.Uni-Erlangen.de

Articles citing this

Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 10.04

Biomarkers for epithelial-mesenchymal transitions. J Clin Invest (2009) 8.76

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99

WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47

Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis (2008) 2.86

Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A (2006) 2.60

Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology (2011) 2.33

Beta-catenin--a linchpin in colorectal carcinogenesis? Am J Pathol (2002) 2.18

Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J (2008) 2.05

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73

Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma. J Gastroenterol Hepatol (2012) 1.70

Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66

The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression. Clin Exp Metastasis (2008) 1.65

Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene (2009) 1.64

Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci U S A (2002) 1.57

Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol (2000) 1.56

β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis. Gut (2011) 1.40

Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets (2011) 1.38

Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol (2000) 1.33

Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer. Diagn Pathol (2013) 1.28

Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation. PLoS One (2008) 1.27

Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res (2011) 1.25

Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol (2002) 1.25

APC mutation and tumour budding in colorectal cancer. J Clin Pathol (2003) 1.24

Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling. Cancer Res (2012) 1.23

LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer. J Transl Med (2010) 1.20

Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. World J Gastroenterol (2008) 1.18

Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci (2010) 1.15

Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness. Br J Cancer (2008) 1.13

The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β. Cancer Microenviron (2009) 1.13

Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am J Pathol (2002) 1.09

Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol (2001) 1.07

Notch: architect, landscaper, and guardian of the intestine. Gastroenterology (2011) 1.03

L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions. BMC Mol Biol (2010) 1.03

PPAR gamma, bioactive lipids, and cancer progression. Front Biosci (Landmark Ed) (2012) 1.01

Activation of c-MET induces a stem-like phenotype in human prostate cancer. PLoS One (2011) 0.98

Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients. Diagn Pathol (2013) 0.95

Molecular imaging of metastatic potential. J Nucl Med (2008) 0.94

Molecular and pathogenetic aspects of tumor budding in colorectal cancer. Front Med (Lausanne) (2015) 0.94

Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma. Clin Exp Metastasis (2004) 0.93

Glycogen Synthase Kinase-3beta regulates Snail and beta-catenin during gastrin-induced migration of gastric cancer cells. J Mol Signal (2010) 0.91

CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation. Cell Rep (2015) 0.91

Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients. J Zhejiang Univ Sci B (2005) 0.90

Molecular targets and pathways involved in liver metastasis of colorectal cancer. Clin Exp Metastasis (2015) 0.90

The Notch ligand Delta-like 1 integrates inputs from TGFbeta/Activin and Wnt pathways. Exp Cell Res (2011) 0.88

Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer. PLoS One (2012) 0.87

Grape seed extract suppresses MDA-MB231 breast cancer cell migration and invasion. Eur J Nutr (2013) 0.85

Vitamin D and colon cancer. World J Gastrointest Oncol (2014) 0.85

Wnt signaling in cancer stem cells and colon cancer metastasis. F1000Res (2016) 0.84

The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma. Int J Colorectal Dis (2010) 0.84

Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer. Oncol Lett (2014) 0.84

Expression of ADAM15 in lung carcinomas. Virchows Arch (2005) 0.84

Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma. Br J Cancer (2002) 0.83

Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry. Thyroid (2013) 0.83

An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progression. PLoS One (2011) 0.83

Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters. BMC Cancer (2013) 0.83

E-cadherin and β-catenin adhesion proteins correlate positively with connexins in colorectal cancer. Oncol Lett (2014) 0.82

Expression and localization of axin 2 in colorectal carcinoma and its clinical implication. Int J Colorectal Dis (2013) 0.82

Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood. Cancer Prev Res (Phila) (2014) 0.81

Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment. J Transl Med (2013) 0.81

Determinants of metastatic competency in colorectal cancer. Mol Oncol (2017) 0.80

Calcein-effluxing human colon cancer cells are enriched for self-renewal capacity and depend on β-catenin. Oncotarget (2013) 0.80

Comprehensive suppression of all apoptosis-induced proliferation pathways as a proposed approach to colorectal cancer prevention and therapy. PLoS One (2014) 0.80

Wnt2 complements Wnt/β-catenin signaling in colorectal cancer. Oncotarget (2015) 0.78

Expression of wingless-type mouse mammary tumor virus integration site family pathway effectors in lymphatic and hepatic metastases of patients with colorectal cancer: Associations with the primary tumor. Oncol Lett (2015) 0.77

Cancer stemness in Apc- vs. Apc/KRAS-driven intestinal tumorigenesis. PLoS One (2013) 0.77

Snail heterogeneity in clear cell renal cell carcinoma. BMC Cancer (2016) 0.77

Tumour budding in colorectal cancer: what do we know and what can we do? Virchows Arch (2015) 0.77

Commitment of chondrogenic precursors of the avian scapula takes place after epithelial-mesenchymal transition of the dermomyotome. BMC Dev Biol (2010) 0.76

HNPCC-associated synchronous early-stage signet-ring cell carcinomas of colonic origin. A comparative morphological and immunohistochemical study of an intramucosal and a submucosal example. Virchows Arch (2008) 0.75

miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression. Oncotarget (2016) 0.75

Calcium, a Cell Cycle Commander, Drives Colon Cancer Cell Diffpoptosis. Indian J Clin Biochem (2016) 0.75

Biomarkers for EMT and MET in breast cancer: An update. Oncol Lett (2016) 0.75

Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma. Int J Clin Exp Pathol (2015) 0.75

[In situ analyses of molecular mechanisms of colorectal carcinogenesis]. Pathologe (2013) 0.75

[Plasticity of WNT signaling activity in colorectal cancer]. Pathologe (2012) 0.75

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection. PLoS One (2017) 0.75

[Morphogenetic aspects of colorectal cancer]. Pathologe (2003) 0.75

Articles by these authors

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99

Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19

Exons encode functional and structural units of chicken lysozyme. Proc Natl Acad Sci U S A (1980) 4.01

Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47

Central nervous system lesions and cervical disc herniations in amateur divers. Lancet (1995) 2.84

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78

The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis (2001) 2.71

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69

Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum (2001) 2.66

Suppression of the btuB451 mutation by mutations in the tonB gene suggests a direct interaction between TonB and TonB-dependent receptor proteins in the outer membrane of Escherichia coli. Gene (1988) 2.54

Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science (1990) 2.50

Multiple mRNAs are generated from the chicken lysozyme gene. Cell (1981) 2.46

CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23

Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol (2013) 2.06

[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03

Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res (2001) 1.83

UV-induced skin changes due to regular use of commercial sunbeds. Photodermatol Photoimmunol Photomed (2002) 1.81

A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol (2009) 1.81

The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res (1973) 1.77

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73

Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease. Hum Pathol (2000) 1.71

The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69

Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67

Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66

[Suture of trocar puncture sites after laparoscopy]. Zentralbl Chir (1997) 1.66

Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62

Is there a disadvantage to radical lymph node dissection in colon cancer? Int J Colorectal Dis (2012) 1.61

Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest (1990) 1.60

Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr (1995) 1.59

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut (2005) 1.59

Calcium carbonate (CaCO3): an efficient and safe phosphate binder in haemodialysis patients? A 3-year study. Nephrol Dial Transplant (1993) 1.58

Mechanisms regulating cytochrome c release in pancreatic mitochondria. Gut (2008) 1.58

Object-oriented sequence analysis: SCL--a C++ class library. Comput Appl Biosci (1996) 1.58

The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis (2003) 1.54

[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52

Development of a standard set of microsatellite reference alleles for identification of grape cultivars. Theor Appl Genet (2004) 1.52

[S3-guideline colorectal cancer version 1.0]. Z Gastroenterol (2013) 1.51

Laparoscopic resection of sigmoid diverticulitis. Results of a multicenter study. Laparoscopic Colorectal Surgery Study Group. Surg Endosc (1999) 1.47

Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer (2011) 1.46

[Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status]. Strahlenther Onkol (1998) 1.45

[Resection of colorectal liver metastases. What prognostic factors determine patient selection?]. Chirurg (2001) 1.44

[The measurement of the femoral torsion angle in children by NMR tomography compared to CT and ultrasound]. Rofo (1995) 1.42

Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group. Lancet (1995) 1.42

Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease. Acta Neurol Scand (1991) 1.42

Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum (2000) 1.40

Weight reduction after gastric bypass and horizontal gastroplasty for morbid obesity. Results after 10 years. Eur J Surg (1994) 1.40

[Intraductal papillary mucinous neoplasms of the pancreas: pro surgical therapy--pro surveillance]. Z Gastroenterol (2008) 1.39

Innate immunity in cystic fibrosis lung disease. J Cyst Fibros (2012) 1.38

Traffic casualties. I. Physical and social sequelae: a follow-up of 3000 traffic accidents. Dan Med Bull (1972) 1.38

Concentration camp survivors in Denmark persecution, disease, disability, compensation. A 23-year follow-up. A survey of the long-term effects of severe environmental stress. Dan Med Bull (1970) 1.35

Plexiform angiomyxoid myofibroblastic tumour: differential diagnosis of gastrointestinal stromal tumour in the stomach. J Clin Pathol (2008) 1.33

Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis (2003) 1.30

Heterogeneity among Whipple's-disease-associated bacteria. Lancet (1994) 1.28

Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum (2000) 1.27

Mechanisms of sulfadoxine resistance in Plasmodium falciparum. Mol Biochem Parasitol (1986) 1.27

The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology (1998) 1.26

A high-resolution reference map for cytoplasmic and membrane-associated proteins of Corynebacterium glutamicum. Electrophoresis (2001) 1.24

Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol (1999) 1.24

Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol (1998) 1.21

Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro. J Parasitol (1986) 1.21

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest (1988) 1.21

S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20

Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum (1998) 1.20

Late pulmonary metastasis in uterine PEComa. J Clin Pathol (2003) 1.20

Surgical therapy for distant metastases of malignant melanoma. Cancer (2000) 1.20

[Aspirations of medical students: "planning for a secure career" - results of an online-survey among students at five medical schools in Germany]. Dtsch Med Wochenschr (2011) 1.19

A hundred patients with vertical rectus abdominis myocutaneous (VRAM) flap for pelvic reconstruction after total pelvic exenteration. Int J Colorectal Dis (2014) 1.19

Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science (1983) 1.17

Epidemiology of Whipple's disease in Germany. Analysis of 110 patients diagnosed in 1965-95. Scand J Gastroenterol (1997) 1.16

Radical operations for carcinoma of the gallbladder: present status in Germany. World J Surg (1991) 1.15

Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J Pathol (1999) 1.14

Anastomotic leakage after low rectal stapler anastomosis: significance of intraoperative anastomotic testing. Eur J Surg Oncol (2003) 1.14

Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut (1997) 1.13

High-risk groups of patients with Stage II colon carcinoma. Cancer (2001) 1.13

CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med (2001) 1.13

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy. Eur J Surg Oncol (2008) 1.11

Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch (1996) 1.10

Prospective multicenter study of the quality of oncologic resections in patients undergoing laparoscopic colorectal surgery for cancer. The Laparoscopic Colorectal Surgery Study Group. Dis Colon Rectum (1998) 1.10

Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. Scand J Gastroenterol (1999) 1.10

Influence of sample collection and preanalytical sample processing on the analyses of biological markers in the European multicentre study IDEFICS. Int J Obes (Lond) (2011) 1.10

Chronic sacral spinal nerve stimulation for fecal incontinence: long-term results with foramen and cuff electrodes. Dis Colon Rectum (2001) 1.10

Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol (2001) 1.09

Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol (1996) 1.09

Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol (2001) 1.08

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306. Ann Oncol (2012) 1.08